Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Multiple Myeloma; Neoplasms, Plasma Cell Phase 2 ClinicalTrials
Granulomatous Disease, Chronic Phase 2 ClinicalTrials
Osteosarcoma Phase 1 ClinicalTrials
CONTENTS